GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Common Stock

Medicus Pharma (Medicus Pharma) Common Stock : $19.84 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Common Stock?

Medicus Pharma's quarterly common stock increased from Jun. 2023 ($0.20 Mil) to Sep. 2023 ($19.84 Mil) but then stayed the same from Sep. 2023 ($19.84 Mil) to Dec. 2023 ($19.84 Mil).

Medicus Pharma's annual common stock stayed the same from Dec. 2021 ($0.20 Mil) to Dec. 2022 ($0.20 Mil) but then increased from Dec. 2022 ($0.20 Mil) to Dec. 2023 ($19.84 Mil).

Medicus Pharma Common Stock Historical Data

The historical data trend for Medicus Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Common Stock Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23
Common Stock
0.20 0.20 19.84

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only 0.20 0.20 0.20 19.84 19.84

Medicus Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Medicus Pharma (Medicus Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Common Stock
Comparable Companies
Traded in Other Exchanges
MDCX:Canada
Address
100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Website
http://www.medicuspharma.com
Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023